Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28797706 | 0.85 | ALDH1A1 (0.35) | ALDH1A1TDP1TSHRCA1CA2 | |
| SCHEMBL17154314 | 0.79 | TSHR (0.35) | ALDH1A1TSHRLMNABBOX1EHMT2 | |
| SCHEMBL5694564 | 0.77 | ALDH1A1 (0.35) | ALDH1A1TDP1TSHRCA1CA2 | |
| SCHEMBL9440080 | 0.77 | LMNA (0.33) | ALDH1A1TSHRALOX12LMNAACHE | |
| SCHEMBL25308488 | 0.76 | CA4 (0.59) | ALDH1A1TDP1CA1CA2CA9 | |
| SCHEMBL28748541 | 0.75 | ALDH1A1 (0.40) | ALDH1A1TDP1TSHRCA1CA2 | |
| SCHEMBL26674 | 0.75 | ALDH1A1 (0.40) | ALDH1A1TDP1TSHRCA1CA2 | |
| SCHEMBL8881696 | 0.72 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCA1CA2 | |
| Phosphine SCHEMBL20701190 | 0.72 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCA1CA2 | |
| Fluoride SCHEMBL18936426 | 0.72 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107417618-A | The synthetic method of benzophenanthrene benzoyloxy alkynes biphenyl alkynes benzene bridging list imines dihexyl | 桂林理工大学 | 2017-12-01 | — | — | CN | claimed |
| CN-107082762-A | The synthetic method of benzophenanthrene benzoyloxy alkynes benzyne benzene Qiao Lian perylene list imines dihexyls | 桂林理工大学 | 2017-08-22 | — | — | CN | claimed |
| CN-107043352-A | The synthetic method of benzophenanthrene benzoyloxy alkynes benzene Qiao Lian perylene list imines dihexyls | 桂林理工大学 | 2017-08-15 | — | — | CN | claimed |
| WO-2023182195-A1 | COMPOSITION FOR FORMING CAVITY | 日産化学株式会社 | 2023-09-28 | — | — | WO | disclosed |
| EP-3331864-B1 | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP (KR) | 2021-11-03 | — | — | EP | disclosed |
| WO-2021161360-A1 | EPOXY RESIN COMPOSITION, EPOXY RESIN CURED PRODUCT, AND METHOD FOR PRODUCING EPOXY RESIN CURED PRODUCT | 三菱電機株式会社 | 2021-08-19 | — | — | WO | disclosed |
| US-10717716-B2 | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2020-07-21 | — | — | US | disclosed |
| CN-107021983-B | The resource recycling Application way of butyl octanol unit rhodium-containing waste liquid | 山东博苑医药化学有限公司 | 2018-03-30 | — | — | CN | disclosed |
| CN-107827823-A | The preparation method of 4,5 dibromo imidazoles | 大连奇凯医药科技有限公司 | 2018-03-23 | — | — | CN | disclosed |
| US-20170275312-A1 | PHOSPHINIC VANADIUM COMPLEX, CATALYTIC SYSTEM COMPRISING SAID PHOSPHINIC VANADIUM COMPLEX AND PROCESS FOR THE (CO) POLYMERIZATION OF CONJUGATED DIENES | VERSALIS S.P.A. (IT) | 2017-09-28 | — | — | US | disclosed |
| EP-3107521-A1 | ADHESIVE BONDING COMPOSITION AND USE THEREOF | 3M Innovative Properties Company (US) | 2016-12-28 | — | — | EP | disclosed |
| US-9394273-B2 | Therapeutic prostaglandin receptor agonists | ALLERGAN, INC. (US) | 2016-07-19 | — | — | US | disclosed |
| US-20150329518-A1 | THERAPEUTIC PROSTAGLANDIN RECEPTOR AGONISTS | ALLERGAN, INC. | 2015-11-19 | — | — | US | disclosed |
| WO-2015126865-A1 | ADHESIVE BONDING COMPOSITION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-08-27 | — | — | WO | disclosed |
| CN-101333234-B | Industrial production method for clindamycin or salts thereof | CHONGQING CARELIFE PHARMACEUTICAL CO LTD | 2012-06-13 | — | — | CN | disclosed |
| CN-101333234-A | Industrial production method for clindamycin or salts thereof | CHONGQING CARELIFE PHARMACEUTI (CN) | 2008-12-31 | — | — | CN | disclosed |
| US-20080280876-A1 | Novel oxadiazole compounds | ABBVIE INC. | 2008-11-13 | — | — | US | disclosed |
| CN-101084210-A | Process | DANISCO (DK) | 2007-12-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275312-A1 | PHOSPHINIC VANADIUM COMPLEX, CATALYTIC SYSTEM COMPRISING SAID PHOSPHINIC VANADIUM COMPLEX AND PROCESS FOR THE (CO) POLYMERIZATION OF CONJUGATED DIENES | PNPO, MVD, INPP5D | ALDH1A1 4417/4885TDP1 3535/4885TSHR 1259/4885 |
| US-20080280876-A1 | Novel oxadiazole compounds | S1PR3, S1PR1, S1PR2 | ALDH1A1 4044/4885TDP1 2946/4885TSHR 1235/4885 |
| US-20150329518-A1 | THERAPEUTIC PROSTAGLANDIN RECEPTOR AGONISTS | PTGIR, PTGDR, PTGFR | ALDH1A1 972/4885TDP1 1895/4885TSHR 232/4885 |
| US-10717716-B2 | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | HDAC1, HDAC5, HDAC2 | ALDH1A1 152/4885TDP1 1817/4885TSHR 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.